Can-Fite BioPharma Ltd. (NYSE:CANF) Q1 2020 Results Conference Call June 1, 2020 8:30 AM ET
Company Participants
Bob Yedid - LifeSci Advisors
Pnina Fishman - CEO
Motti Farbstein - CFO
Conference Call Participants
Jason Kolbert - Dawson James
Vernon Bernardino - H.C. Wainwright
Operator
Greetings and welcome to the Can-Fite BioPharma First Quarter 2020 Business Update Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions].
It is now my pleasure to introduce your host, Mr. Bob Yedid of LifeSci Advisors. Thank you. You may begin.
Bob Yedid
Thank you, and thanks to everyone for joining us for the Can-Fite’s first quarter 2020 conference call. Today, the company will provide a financial update for the quarter ended March 31, 2020, as well as latest developments in Can-Fite's advanced stage clinical pipeline.
On the call today are Can-Fite's CEO, Dr. Pnina Fishman; and the company's CFO, Motti Farbstein. At the end of the call, we will have a question-and-answer session.
We'll start with a brief Safe Harbor statement. This conference call may contain forward-looking statements about Can-Fite's expectations, beliefs or intentions regarding, among other things, market risks and uncertainties, its product development efforts, business, financial condition, results of operations, strategies or prospects. Forward-looking statements can be identified by the use of forward-looking words such as believe, expect, intend, plan, may, should or anticipate or their negatives or other variations of these words or other comparable words or by the fact these statements do not relate strictly to historical or current matters. Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that can cause Can-Fite's actual results to differ materially from any future results expressed or implied by the forward-looking statements.
- Read more current CANF analysis and news
- View all earnings call transcripts